booksshare.net -> -> -> .. -> " - " -> 246

- - ..

.., .. - .: , 2002. 182 c.
( ): pharmazeutischewirkstoffe1982.djvu
<< 1 .. 240 241 242 243 244 245 < 246 > 247 248 249 250 251 252 .. 345 >>

Solfanrone® (Francia Farm.)-Komb. J: Sulzoi® (Yoshitomi)
USA: Cerazole® (Beecham) Coco-Thiazole® (Lilly)
Sulfinpyrazon
(Sulphinpyrazone)
57-96-5
l,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione
S2U Qb-s-сн,-
COOC2H5 <Q>-S - CH2-СНг - CH
COOC2H5
Antiarthriticum;
Uricosuricum;
Thrombocyten-Aggrega-tionshemmer (zur Senkung der Post-infarkt-Mortalitat)
HN-NH
АгЛ
2-(2-Phenylthioethyl)-malonsaure-
diethylester
Hydrazobenzol
ij,
6
-o
846 S Sulfinpyrazon - Sulfisomidin
<^V-SO-CH2-CH3 n
■SO-CH2-CH3
Н202УСНЗС00Н
Wasser-
stoflper-
oxid
Sulfinpyra2on
DOT 15,61 (1979). DBP 903 578 (Geigy; Anm. 1951; CH-Prior. 1950). USP 2 700 671 (Geigy; ert. 1955; CH-Prior. 1950). CH-P 303 938 (Geigy; Anm. 1950). R. Pfister, F. Hafliger, Helv. Chim. Acta 44,232 (1961).
D: Anturano® (Geigy) I: Enturen® (Geigy)
F: Anturan® (Geigy) J: Anturan® (Ciba-Geigy-Fujisawa)
GB: Anturan® (Geigy) USA: Anturane® (Geigy)
Sulfisomidin 515-64-0 Chemotherapeuticum
(Sulphasomidine)
/V’-(2,6-dime thyl-4-pyrimidinyl)suifaniIamide
a
4-Nitrobenzolsulfonyt-
chlorid
CH3
6-Дтто-2,4-
dimethylpyrimidin
Sulfisomidin
b
CH3
4-Acetamidobenzolsulfonylchlorid 6-Ammo-2,4-
dimethylpyrimidin
NaOH
Sulfisomidin
USP 2 351 333 (Geigy; en. 1944; CH-Prior. 1940).
D: Aristamid® (Nordmark) Elkosin®(Ciba)
F: Elcosine® (Ciba)
J: Domion® (Dainippon)
Entamidine® (Nippon Shoji) USA: Elkosin® (Ciba)-Geigy
Sulforidazin - Sulfoxone-Sodium - Sulindac S 847
Sllfforidazin 14759-O6-9 Neurolepticum
10-[2-(l-methyl-2-piperidyl)ethyl]-2-methylsulfonyl-phenothiazine
t. NaNH2
S02-CH3
2-Methyisulfonyl-
phenothiazin
2. ci-ch2-ch,-(;
H3C
1. Natnumamid
2. 2-f2-Chler*thyU-1-melhylpiperidin
FP 1459476 (Sandoz; Anm. 30.11.1965; CH-Prior. 15.9.1965). Alternativ-Synthese:
FP 1 363 683 (Sandoz; Anm. 17.7.1963; CH-Prior. 19.7.196-2, 23.10.1962).
D: Inofai® (Sandoz)
Sulfoxone-Sodium 144-76-3 Chemotherapeuticum
(Aldesulfon Natrium) 144-75-2 Di-Na-Salz (gegen Lepra)
methanesulfinic acid [sulfonylbis(l,4-phenyleneimino)]bis-,disodiumsalt
H2N_O~S0!^O_™2 + 2 Na0_S0_CH2_°H —*■
//
Dapson Natnumformaldebyd-
(s. S. 267) sulfoxylat
NaO-SO-CH2-NH—NH-CH;-SO-ONa Sutfoxone- Natrium
USP 2 234 981 (US-Secretary of the Treasury; ert. 1941; Anm. 1938). USA: Diasone Sodium (Abbott)
Sulindac 38194-50-2 Antiphlogisticum;
Analgeticum; Antipyreticum
(Z)-5-fluoro-2-methyl-l-[p-(methylsuffinyl)benzylidene]indene-3-acetic acid
848 S Sulindac - Sulmetozin
£f°
4-Fluorbenz-
aldehyd
(H3C-CH2-C0)20
Propionsaureanhydnd
H3C-CH2-COONa
.J0r‘
.с H2^ ^СНз
CH I
COOH
Polyphosphorsaure, 95°C
,-Or'
CH^ CH3
COOH
4-Fluor-a-methylzimtsaure
fXX^-chs
CN
1. H2C /СН3СООН /CHjCOONHi
NCOOH
2. КОМ
3 HCl_
1 Cyaressigsaure
4-Fluor-a-methyldihydro-
simtsaure
5-Fluor-2-methyl-
3-mdanon
1С^~СНз
CH2-COOH
5-Fluor-2-methylmden-
3-essigsaure
4-Methyl thiobenzaldehyd
CH2-COOH
5-F{uor-2-methy(-J-(<i-methylthjo-benzyliden)- 3-indenylessigsaure
Natnumperjodat
CH3
^СНз CH2-COOH Sulindac
DOT 12,496 (1976). DBP 2039426 (Merck & Co.; Anm. 7.8.1970; USA-Prior. 8.8.1969, 1.5.1970). USP 3 654 349 (Merck & Co.; ert. 4.4.1972,- Prior. 8.8.1969,1.5.1970). USP 3 647 858 (Merck & Co.; ert. 7.3.1972; Prior. 19.11.1969,1.5.1970). USP 3 882 239 (Merck & Co.; ert. 6.5.1975; Prior. 21.1.1971, 6.9.1972,13.6.1974).
D: lmbaral® (Sharp + Dohme) I: Clinoril® (Merck Sharp + Dohme)
F: Arthrocine® (Merck Sharp + Dohme-Chibret) USA: Clinoril® (Merck Sharp + Dohme) GB: Clinoril® (Merck Sharp + Dohme)
Sulmetozin 35619-65-9 Magensaure-
(Trithiozin) sekretionshemmer; Ulcustherapeuticum
4-(3,4,5-trimetfaoxythiobenzoyl)morpholine
H3C0 H3C0
нз‘
3,4,5-Tnmethoxy- Morpholin Schwefel
benzaldehyd
hh )o
Sulmetozin
Sulmetozin-Suloctidil-Sulpirid S 849
DOF 1,397 (1976).
DOT 14,175(1978).
DOS 2102 246 (ISF; Anm. 19.1.1971; I-Prior. 31.7.1970). S. Banfi et al., Chim. Ther. 4,462 (1973).
I: Tresanil® (Italseber)
Suloctidil 54063-56-8 Vasodilatator
/?-(isopjopy]thio)-cf-[l-{octy]arnjno)ethy]]benzyj alcohol
СНэ о СНз
H3C-CH-S-£^>-C-CH-Br + H2N-|CH2)7-CH3 Ch]0H>
a-Brom-/i-isopropylthioproptophenon Octyiamm
СНз О СНз
I 1 NaBH4/h
HaC-CH-S-^ >-C-CH-NH-(CH2)7-CH3 —Г-
\—/ Natrjum-
borhydr'd
СНз ОН СНз j
НзС-СН-S—ff V-CH-CH-NH-(CH2b-CH3
DOT 13,107(1977).
DOS 2334404 (Continental Pharma; Anm. 6.7.1973; GB-Prior. 9.4.1973) Weitere Verfahren:
Span-P460766 (Lab. F. Bonet; Anm. 14.7.1977).
JP 5 4005 928 (Mitsubishi; Anm. 15.6.1977).
JP 5 4005 929 (Mitsubishi; Anm. 15.6.1977).
JP 5 4005 930 (Mitsubishi; Anm. 15.6.1977).
JP 5 4019 927 (Zambeletti; Anm. 11.7.1977).
Anwendung als Vasodilatator:
JP 5 4005 930 (Mitsubishi; Anm. 1979).
D: Fluversin® (Searle)
GB: Duloctil® (Searle)
I: Cerebro® (Sidus)
EuvasaJ® (Selvi)
Llangene® (Farmochimica) Locton® (Lepetit) Polivasol® (Coli)
Sulpirid 15676-16-1 Psychotropicum;
Spasmolyticum;
Antiemeticum
<< 1 .. 240 241 242 243 244 245 < 246 > 247 248 249 250 251 252 .. 345 >>

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

, ?
2009 BooksShare.
.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed